Diabetes in Pregnancy
Pre-existing and gestational diabetes care has advanced with technology and the GLP-1 timing question. The session covers CGM in pregnancy (the new ATTAIN-MOMs trial), automated insulin delivery in T1D pregnancy (CONCEPTT extension), gestational diabetes screening (one-step vs two-step IADPSG debate), postpartum diabetes prevention, GLP-1 timing around pregnancy (washout requirements), and the LEAD-MOM gestational outcomes. Discussion addresses maternal-foetal outcomes with technology use, T2D in pregnancy management, hypertensive disorders and pre-eclampsia management, the comparison of insulin vs metformin in GDM, breastfeeding considerations on diabetes medications, and equity in diabetes-in-pregnancy care access.
- ATTAIN-MOMs CGM trial
- CONCEPTT AID in pregnancy
- GDM screening (one vs two step)
- Postpartum prevention
- GLP-1 washout requirements
- Pre-eclampsia management
- Insulin vs metformin in GDM
- Breastfeeding on diabetes meds
Explore the full GSOD 2027 program
- 01GLP-1 & Incretin Therapies
- 02Bariatric Surgery
- 03Childhood & Adolescent Obesity
- 04Obesity Genetics & Epigenetics
- 05Metabolic Syndrome
- 06Behavioral & Lifestyle Interventions
- 07Gut Microbiome & Metabolism
- 08Health Equity in Obesity Care
- 09Policy, Environment & Prevention
- 10Weight Loss Maintenance
- 11Eating Disorders & Obesity
- 12Sarcopenic Obesity
- 13Hormonal Drivers
- 14Cardiometabolic Complications
- 15MASH & Obesity-Liver Axis
- 16Sleep & Obesity
- 17Workplace & School Programs
- 18Pharmacotherapy Pipeline
- 19Type 1 Diabetes
- 20Type 2 Diabetes
- 21Diabetic Retinopathy
- 22Diabetic Neuropathy
- 23Diabetic Kidney Disease
- 24Polycystic Ovary Syndrome
- 25Thyroid & Weight
- 26Insulin Resistance
- 27Lipid Metabolism
- 28Body Composition
- 29Body Image & Mental Health
- 31Telemedicine in Obesity
- 32Endocrine Disruptors
- 33Health Coaching
- 34Geriatric Obesity
- 35Stigma & Communication